Qiuhong Wang

Qiuhong Wang
Qiuhong Wang
Associate Professor, Center for Food Animal Health, Department of Animal Sciences, and Department of Veterinary Preventive Medicine
The Ohio State University
Degree Information: 
Ph.D, The Ohio State University
Master of Science, University of Tokyo
Bachelor of Medicine (M.D. equivalent), Beijing Medical University, China

Diarrhea is the second leading cause of death among children under the age of 5 and is a common disease for young animals. Dr. Wang’s research focus is on enteric caliciviruses and coronaviruses, including diagnosis of viral infections, molecular epidemiology, adaptation of enteric viruses in cell culture, mechanisms of virus attenuation, interspecies transmission of viruses, the mechanisms of enteric virus transmission through leafy greens, and the development of vaccines using conventional and reverse genetics technologies.

Human noroviruses (HuNoVs) are the leading cause of foodborne illnesses in the US. Contaminated food is a major transmission vehicle for this virus. Among all kinds of foods, leafy greens are ranked number one in norovirus-outbreaks, followed by fresh fruits/nuts and shellfish. Our laboratory studies the mechanisms of HuNoV binding to leafy greens, how viral particles are transported from roots to leaves, and if they retain infectivity in plants. Such knowledge will lead to develop technologies to control HuNoV contamination of leafy greens.

Porcine epidemic diarrhea virus (PEDV) causes a high mortality rate (up to 100 percent) in neonatal pigs. To control the disease, an effective vaccine is urgently needed, but none is available in the US. Theoretically, the most effective vaccines for PEDV are live and attenuated vaccines. However, knowledge of the molecular attenuation mechanisms of PEDV and other genetically related coronaviruses is limited. Our laboratory exploits conventional (e.g., cell culture adaptation) and state-of-the-art (e.g., reverse genetics) technologies to generate PEDV strains with reduced virulence, to identify genomic hot spots related to attenuation, and to design PEDV vaccine candidates. The knowledge gained will advance the development of a safe attenuated PEDV vaccine and will aid in innovative vaccine design against other fatal animal and human coronavirus diseases, such as COVID-19.